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Background Context: The accurate determination of a patient’s functional status is 2 
necessary for therapeutic decision-making and to critically appraise treatment efficacy. 3 
Current subjective patient-reported outcome measure (PROM)–based assessments have 4 
limitations and can be complimented by objective measures of function. 5 
Purpose: To systematically review the literature and provide an overview on the available 6 
objective measures of function for patients with degenerative diseases of the lumbar spine.  7 
Study Design/Setting: Systematic review of the literature. 8 
Methods: The PRISMA guidelines were followed. Two reviewers independently searched the 9 
PubMed, Web of Science, EMBASE and SCOPUS databases for permutations of the words 10 
“objective”, “assessment”, “function”, “lumbar” and “spine”, including articles on human 11 
subjects with degenerative diseases of the lumbar spine that reported on objective measures 12 
of function, published until September 2018. No funding was received. The authors report no 13 
conflicts of interest. 14 
Results: Of 2389 identified articles, 82 were included in the final analysis. There was a 15 
significant increase of 0.12 per year in the number of publications dealing with objective 16 
measures of function since 1989 (95% CI 0.08–0.16, p<0.001). Some publications studied 17 
multiple diagnoses and objective measures. The US was the leading nation in terms of 18 
scientific output for objective outcome measures (n=21; 25.6%), followed by Switzerland 19 
(n=17; 20.7%), Canada, Germany and the United Kingdom (each n=6; 7.3%). Our search 20 
revealed 21 different types of objective measures, predominantly applied to patients with 21 
lumbar spinal stenosis (n=67 publications; 81.7%), chronic/unspecific low back pain (n=28; 22 
34.2%) and lumbar disc herniation (n=22; 26.8%). The Timed-Up-and-Go (TUG) test was the 23 
most frequently applied measure (n=26 publications; 31.7%; cumulative number of reported 24 
subjects: 5181), followed by the Motorized Treadmill Test (MTT; n=25 publications; 30.5%, 25 
1499 subjects) and with each n=9 publications (11.0%) the Five-Repetition Sit-To-Stand test 26 
(5R-STS; 955 subjects), as well as accelerometry analyses (336 subjects). The reliability and 27 
validity of many of the less-applied objective measures was uncertain. There was profound 28 
heterogeneity in their application and interpretation of results. Risk of bias was not assessed. 29 
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Conclusions: Clinical studies on patients with lumbar degenerative diseases increasingly 1 
employ objective measures of function, which offer high potential for improving the quality of 2 
outcome measurement in patient-care and research. This review provides an overview on 3 
available options. Our findings call for an agreement and standardization in terms of test 4 
selection, conduction and analysis to facilitate comparison of results across cohorts.  5 
 6 
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Abbreviations: 1 
5R-STS – Five-Repetition Sit-To-Stand 2 
6MWT – 6-minute walking test 3 
6MWD - 6-minute walking distance 4 
AST – alternative step test 5 
BMI – body mass index 6 
DDD – degenerative disc disease 7 
DTFS – distance to first symptoms 8 
EQ-5D – Euro-Qol 5 D 9 
GPS – Global Positioning System 10 
hrQoL – health-related quality of life 11 
ICC – intraclass correlation coefficient 12 
IF – impact factor 13 
kpm – kilogram force meter (Kilopondmeter) 14 
LBP – low back pain 15 
LDH – lumbar disc herniation 16 
LSS – lumbar spinal stenosis 17 
m - meters 18 
MCID – minimum clinically important difference 19 
min - minutes 20 
MTT – Motorized Treadmill Test 21 
ODI – Oswestry disability index 22 
OFI – objective functional impairment 23 
PCS – physical component summary 24 
PICOS – participants, interventions, comparators, outcomes, and study design 25 
PROMs – patient reported outcome measures 26 
RCT – randomized controlled trial 27 
RMDI – Roland-Morris disability index 28 
rpm – revolutions per minute 29 
TAT – total ambulation time 30 
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TTFS – time to first symptoms 1 
TUG – Timed Up and Go test 2 
s - seconds 3 
SD – standard deviation 4 
SM – standard error of measurement 5 
SF-12 – short-form 12 6 
SPWT – self-paced walking test 7 
SSSQ – Swiss Spinal Stenosis Questionnaire 8 
SWT – Shuttle Walking Test 9 
VAS – visual analog scale 10 
VCF – vertebral compression fracture 11 
W – Watt (unit of power) 12 
WC – weight carrying 13 
14 
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Introduction 1 
The goals of surgical interventions for degenerative diseases of the spine are relieving pain, 2 
and improving function and health-related quality of life (hrQoL).[1] Choice of surgical 3 
intervention is complex and depends on many factors. Knowledge of disease natural history is 4 
required, since pain (and even motor deficit) may respond to conservative therapy.[2] It is 5 
essential to assess pain, functional limitations and reduction of hrQoL as accurately as 6 
possible, since this information serves as a basis for decision-making for or against surgical 7 
treatment. Baseline functional status may be used as a reference, against which the success 8 
or failure of any treatment will be measured.  9 
An important and necessary evolution has taken place in the last decades, away from the 10 
subjective assessment of the treating physician towards a more patient-centered approach.[3] 11 
Focus is now on subjective patient-reported generic or disease-specific outcome measures 12 
(PROMs) for disability and hrQoL, such as e.g., the Oswestry disability index (ODI), the 13 
Roland-Morris disability index (RMDI) or the Short-Form 12/36 (SF-12/SF-36). Furthermore, 14 
generic and disease-specific objective measures of function are gaining increasing attention, 15 
adding a further dimension to the comprehensive patient evaluation. The possibilities of 16 
broadly-available new technologies such as smartphones equipped with accelerometers or 17 
global positioning systems (GPS) have opened additional venues for disability and outcome 18 
measurement in research and healthcare. 19 
As the number of reports pertaining to potential objective measures of function continues to 20 
grow, the aim of this systematic literature review was to provide an overview on currently 21 
available objective measures of function, applicable to patients suffering from degenerative 22 
pathologies of the lumbar spine.  23 
 24 
Material and methods 25 
The guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analyses 26 
(PRISMA) were followed for conducting this systematic review.[4] 27 
 28 
Study selection criteria 29 
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We included articles of human subjects written in English, German or French that met the 1 
following criteria: reporting of one or several objective measures of function, applied to human 2 
patients with degenerative diseases of the lumbar spine. We defined objective measures of 3 
function as being (1) based on a task to be performed by the patient, (2) evaluated using an 4 
objective assessment of the patients' performance on that task (i.e. time taken, repetitions, 5 
etc.), (3) rated by an observer/machine instead of the patient him/herself, and (4) based on a 6 
standardized testing protocol. We did not consider widespread objective methods used in 7 
orthopedics that measure only certain aspects of the human body, e.g., joint mobility with a 8 
goniometer, muscle strength with the help of a Newton meter, or radiological parameters (e.g. 9 
Cobb angle for scoliosis, parameters of sagittal balance, diameter of the spinal canal in the 10 
axial magnetic resonance imaging (MRI)). Furthermore, the search was focused strictly on 11 
outcome measures for patients with degenerative diseases of the lumbar spine; those applied 12 
for trauma (e.g., spinal cord injury), spinal oncology, degenerative cervical pathologies or 13 
cranial neurosurgery were not included. 14 
 15 
Database search and study extraction 16 
A systematic literature was conducted in PubMed, Web of Science, EMBASE and SCOPUS 17 
databases, including articles published until September 2018. We searched for permutations 18 
of the words “objective”, “assessment”, “function”, “lumbar” and “spine” in each database’s 19 
search engine (see Appendices C-F). Full-text papers of which the title and abstract met the 20 
eligibility criteria (Table 1) were rigorously assessed to determine inclusion. References from 21 
each full-text article were similarly re-viewed for inclusion eligibility. The study screening and 22 
data extraction were independently performed by two reviewers (M.N.S. & A.L.H.), and any 23 
discrepancies were resolved by discussion between those two, or with the entire research 24 
group.  25 
 26 
Data collection 27 
Reference data such as the study objective, number of included subjects, cohort and disease 28 
type studied in general, as well as specifically for each type of applied objective measure 29 
were extracted from the selected articles, together with the study design, year of publication, 30 
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country of origin (or country of main data generation in case of international collaborations), 1 
journal name and the journal’s 2017 impact factor (IF, as provided by Thomson-Reuter, 2 
whenever available). The latter was done to estimate the scientific robustness and value of 3 
each outcome measure. We extracted the method of application, as well as any information 4 
regarding its test qualities. The primary objective of each study was characterized as either a 5 
study dedicated to a) exploring qualities of the objective measure (e.g., reliability, validity, 6 
responsiveness, minimum clinically important difference (MCID), satisfaction), b) 7 
characterizing a certain disease by means of the objective measure (e.g., comparing the 8 
functional status of patients with or without spondylolisthesis) or c) investigating a therapeutic 9 
effect (applying the objective measure to compare outcomes between treatment groups). 10 
 11 
Quality assessment of selected studies & establishment of level of evidence  12 
As we did not intend to carry out a meta-analysis and no valid tools were available to evaluate 13 
objective functional tests, we desisted from systematically evaluating quality, level of evidence 14 
and risk of bias of each included study/functional test.  15 
 16 
Analysis 17 
Quantitative statistical analysis was only possible to a limited extent, due to the significant 18 
heterogeneity in included studies’ aim, design and type of objective test. Whenever feasible, 19 
categorical variables were analyzed by Chi-square and continuous variables by two-sample t-20 
tests. Time trends were analyzed by Poisson regression, allowing calculation of robust 21 
standard errors as recommended by Cameron and Trivedi.[5] All analyses were conducted 22 
using Stata v14.2 (College Station, Texas, USA). P-values < 0.05 on two-tailed hypotheses 23 
were considered statistically significant.  24 
 25 
Results 26 
Our database search initially yielded 2389 articles. After title and abstract screening, 2301 27 
articles were excluded because they did not meet the inclusion criteria. 88 potentially eligible 28 
articles remained, of which 29 duplicates were removed. Further 73 citations were added 29 
through backward- and forward citation and hand searching. Thus, 132 articles were retrieved 30 
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for full-text analysis, of which 50 were subsequently excluded because they were irrelevant to 1 
this study. Ultimately, 82 citations were included in this study (Figure 1). A comprehensive 2 
overview on all 82 articles is provided in Supplementary Table 1. 3 
 4 
Disease types 5 
Lumbar spinal stenosis (LSS) was by far the disease most frequently studied by objective 6 
measures of function (n=67 publications; 81.7%), followed by chronic/unspecific low back 7 
pain (LBP; n=28; 34.2%), lumbar disc herniation (LDH; n=22; 26.8%), spondylolisthesis 8 
(n=18; 22.0%), deformity (n=4; 4.9%), vertebral compression fracture (VCF; n=1; 1.2%) or 9 
other types (n=4; 4.9%). 10 
 11 
Time-trend in reporting objective measures of function 12 
There was a profound and significant increase of 0.12 scientific papers per year that included 13 
an objective measure of function across the last decades (95% CI 0.08–0.16, p<0.001; Figure 14 
2). 15 
 16 
Reporting of objective measures of function per country 17 
The USA was the leading nation in terms of overall number of publications that included an 18 
objective measure of function (n=21; 25.6%), followed by Switzerland (n=17; 20.7%), Canada, 19 
Germany and the United Kingdom (each n=6; 7.3%). A comprehensive overview of the 20 
absolute and relative frequency of publications employing an objective measure of function 21 
per country is provided in Figure 3. 22 
 23 
Reporting of objective measures of function per journal 24 
Spine was the leading journal in terms of overall number of publications that included an 25 
objective measure of function (n=19; 23.2%), followed by The Spine Journal (n=8; 9.8%), the 26 
European Spine Journal (n=7; 8.5%), Archives of Physical and Medical Rehabilitation (n=4; 27 
4.9%) and Acta Neurochirurgica, the Journal of Neurosurgery: Spine and World Neurosurgery 28 
with 3 articles each (3.7%; Supplemental Figure 1). 29 
 30 
   
9
Objective tests 1 
Our search revealed 21 different types of objective measures of function, for which a 2 
comprehensive overview is provided in Table 2, including the absolute and relative frequency 3 
of application, study type and disease type for which the measure was applied. The table also 4 
summarizes the cumulative and mean number of reported participants per objective measure. 5 
The scientific value of each measure is estimated by providing the cumulative and mean 6 
impact factor (IF) of the journals that have published articles of each measure. In the table, a 7 
brief description of each objective measure is provided. However, many measures were not 8 
performed according to uniform and standardized protocols, and instructions given to 9 
participants, test protocols and analysis of outcomes profoundly varied across studies for 10 
many identified objective measures of function. 11 
The most frequently applied objective measure was the Timed-Up and Go (TUG) test (n=26 12 
publications; 31.7%) with a cumulative number of 5181 reported subjects. This measure also 13 
applied for the widest range of disease types: LSS, LDH, LBP, spondylolisthesis, spinal 14 
deformity, VCF, and others. We identified 10 articles focusing primarily on characteristics of 15 
the TUG test, 11 articles applying the TUG test to study a disease/condition, and 5 articles 16 
that applied the TUG test to compare outcomes between two different treatment regimes 17 
(Table 2). The TUG test was followed in frequency by the Motorized Treadmill Test (MTT; 18 
n=25 publications; 30.5%; 1499 reported subjects) and both the Five-Repetition Sit-To-Stand 19 
test (5R-STS; n=9 publications; 11.0%; 955 reported subjects), as well as accelometry 20 
analyses (n=9 publications; 11.0%; 336 reported subjects). 21 
Reports applying the 6-minute walking test (6MWT) had the highest cumulative IF (90.73), 22 
followed by those applying the TUG test (69.55) and the MTT (65.21).  23 
A comprehensive overview on all metrics for identified objective measures of function is 24 
provided in Table 2. The most frequently applied, reproducible, reliable and validated 25 
objective measures of function are described in more detail in the following: 26 
 27 
The TUG test 28 
The TUG is a simple test that does not require any special equipment except for a chair and 29 
3m of walking space. It has frequently been applied in patients harboring a multitude of 30 
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degenerative conditions of the lumbar spine. Here, patients sit on a chair and lean back, with 1 
arms resting on the armrests. On the word “Go”, they are asked to get up and walk as fast as 2 
possible to a marked line on the floor at 3m distance. At this line, patients turn around (180°), 3 
return to the chair and sit back down, as quickly as possible. The time between getting up and 4 
sitting down again is recorded in seconds using a stopwatch.[6-8] Besides interpreting raw 5 
test times (in seconds (s)), categorizing patients into those with no, mild, moderate or severe 6 
“objective functional impairment” (OFI) is possible using age- and sex-standardized cut-off 7 
values.[6, 8] Moreover, the calculation of standardized OFI T-scores allows for exact 8 
determination of a patient’s functional condition as a deviation from the normal population.[6-9 
10] Working with OFI rather than TUG test raw values prevents bias naturally introduced by 10 
the high influence of the variables age and sex on the TUG test.[10-12] A free smartphone 11 
app can be utilized for both TUG measurement and automatic OFI calculation (more 12 
information in Appendix A). 13 
The TUG test had excellent intra- (intraclass correlation coefficient (ICC) 0.97) and interrater 14 
reliability (ICC 0.99), with a standard error of measurement (SEM) of 0.21 and 0.23 sec., 15 
respectively.[6] It was shown to discriminate between disability in patients with or without 16 
chronic LBP.[13] Among a set of clinical variables, the TUG test result was the one that 17 
showed the highest correlation with disability and walking capacity.[14] The convergent 18 
validity with PROMs, such as visual analog scale (VAS) back (r=0.25) and leg pain (r=0.29), 19 
RMDI (r=0.38) and ODI (r=0.34), as well as SF-12 physical component summary (PCS; r=-20 
0.32) and EQ-5D (r=-0.28) was demonstrated.[6] In surgical candidates with lumbar 21 
degenerative disc disease (DDD), convergent validity of the TUG test with PROMs of pain 22 
intensity, functional impairment and QoL was even higher after as compared to before the 23 
surgical intervention.[9] Various studies demonstrate that the TUG test is sensitive to a 24 
patient’s postoperative change in function.[7, 9, 15] A change in the TUG test of at least 3.4s 25 
is considered a clinically meaningful change in function (MCID) for patients with lumbar 26 
DDD.[7] For single, but especially for repetitive evaluations, patients preferred the TUG test 27 
over questionnaire-based assessments.[16] 28 
Considering its high intra-rater reliability, a single trial would be sufficient to measure a 29 
participants level of impairment,[6-8] but some studies preferred to calculate the mean of two 30 
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or three TUG trials.[13, 17] While one study suggested that a patients’ body mass index (BMI) 1 
might adversely effect the performance of functional mobility tests,[18] a dedicated report did 2 
not find a significant influence of the BMI on the TUG test.[19] Further research indicated little 3 
or no influence of a patients’ smoking and of the mental health status on the TUG test 4 
result,[20, 21] making this test a particularly interesting option for the functional assessment of 5 
patients with psychiatric comorbidities that often interfere with PROM-based 6 
assessments.[20] 7 
 8 
The MTT 9 
For the MTT, patients are instructed to walk on a calibrated treadmill, usually starting on a 10 
level surface (0% grade) and at an established protocol speed and time. Participants should 11 
not place both hands at the handrails for support, as this can improve their walking capacity 12 
by bending forward;[22-25] holding one handrail for balance purposed is usually allowed, 13 
however. Pain and/or paresthesia can be measured before and after the test; the time of 14 
symptom onset can also be monitored. 15 
Prior studies have proposed to start with 10min at 2mph, increase to 2.5mph for the next 16 
5min, then to 3mph for additional 5min (total of 20min),[26, 27] or to remain at a constant 17 
speed of 2–2.5mph for the complete duration of 15 or 30min.[28-34] Other groups had 18 
participants walk at maximum, individually selected speed for up to 15 or 30min.[22, 23, 35-19 
37] According to the modified Bruce protocol, two warm-up stages of 3min are followed by 20 
incremental increase in speed and gradient.[38-40] Further, other individualized protocols 21 
have been used.[25, 41-43] If a participant is unable to tolerate the standard speed and 22 
distance, the speed is reduced or the test is ended, if necessary. The test is also stopped 23 
when subjects reach a safety endpoint, e.g. 85% of predicted maximal heart rate (220 – 24 
age).[39] 25 
Raw test results are the time of onset or significant increase in symptoms (TTFS = time to first 26 
symptoms; min and s), the total ambulation time (TAT; min and s), the total distance walked 27 
(m), as well as the maximum walking speed (m/s) for protocols that allow individual speed 28 
selection.[26, 28, 35, 43] To the best of the authors’ knowledge, no studies have interpreted 29 
test results in a standardized fashion.  30 
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The authors are also not aware of any study determining the optimal protocol for the MTT in 1 
patients with degenerative disease of the lumbar spine. Studies do suggest, however, that the 2 
additional information gained after 15min of walking time is negligible.[25, 41, 44] The intra-3 
rater reliability of the MTT was high to excellent for both TTFS (ICC 0.90–0.98) and TAT 4 
(0.89–0.96) at 1.2mph or at an individually selected speed.[45] For an individual protocol with 5 
a gradual increase in walking speed, intrarater reliability was equally high (ICC 0.83).[42] As 6 
the MTT protocols differed between studies, reliability is unclear for other protocols. The total 7 
distance walked was significantly less in patients with LSS (mean 292±21m) than in a healthy 8 
control group (409±16m; p<0.01).[42] Convergent validity of the MTT was otherwise 9 
demonstrated with the self-paced walking test (SPWT; r=0.88),[46] self-reported walking 10 
distance (r=0.62),[33] as well as with self-reported symptoms of neurogenic claudication 11 
(r=0.88).[26] Other studies indicated a weak to moderate correlation between the objectively 12 
measured walking distance on the MTT with the walking distance that patients reported being 13 
able to walk.[23, 35] The MTT was shown to be sensitive to change in the postoperative 14 
setting.[44]  15 
The MTT has been primarily studied in patients with LSS so far, and it was applied as an 16 
objective outcome measure in a number of RCTs and observational studies (Table 2). 17 
Despite a similar number of publications reporting on the MTT and the TUG test, the number 18 
of reported subjects was by far less for the MTT. In direct comparison to the SPWT, the MTT 19 
showed poorer internal responsiveness for LSS patients and patients consistently walked 20 
further in the SPWT.[23, 46] Also, a distinct drawback of the MTT is that special equipment 21 
(motorized treadmill) and trained personal is required, whereas other tests (e.g., TUG test, 22 
6MWT) can be performed without additional resources. The potential risks of frightening or 23 
even injuring patients on a motorized treadmill must also be considered, especially when 24 
examining the elderly.[47] 25 
 26 
The 5R-STS 27 
For this test, participants are asked to sit down on an armless chair of standard height (48cm) 28 
and with a hard seat, firmly placed against the wall. With arms folded across the chest and 29 
feet kept flat on the ground (wearing stable footwear) participants are asked to stand up fully 30 
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and sit back down again without using the upper limbs and as fast as possible.[48] In order to 1 
increase discriminative capacity, most previous researchers have asked participants to 2 
perform five repetitions of the test, measuring the overall time to complete, with a maximum of 3 
30 seconds.[18, 48-51]  4 
The test result usually is the time to perform the five trials. Besides reporting raw values (in s), 5 
the 5R-STS was standardized and cut-off values have been proposed to discriminate 6 
between patients with lumber DDD and no (≤10.4s), mild (10.5–15.2s), moderate (15.3–7 
22.0s) or severe OFI (>22.0s).[48] One study asked participants to perform as many 8 
repetitions of the STS test as possible within 30s; the test result being the total number of 9 
repetitions.[52] Other groups only measured the time required to rise from the chair (chair rise 10 
time), without sitting back down.[42, 51, 53] 11 
The 5R-STS’ intra-rater reliability was found to be high for a single (ICC 0.84)[42] and 12 
excellent for five repetitive trials (ICC 0.95–0.98).[18, 48] The test time for a single trial was 13 
significantly longer in patients with LSS (mean 0.99±0.16 sec) than in a healthy control group 14 
(0.57±1.72 sec; p<0.01).[42] For logarithmic 5R-STS test results, moderate convergent 15 
validity was reported in a cohort of n=157 patients with lumbar DDD in terms of RMDI 16 
(r=0.49), ODI (r=0.44), VAS back pain (r=0.31), and the EQ-5D index (r=-0.41; all 17 
p<0.001).[48] Age, body weight and the BMI were shown to influence the result of the 5R-18 
STS test. A patient’s expected “normal” test time (or “targeted 5R-STS performance” after 19 
successful treatment) can be predicted by the formula ta = 0.03 age + 0.15 BMI + 1.7.[48] 20 
 21 
The SPWT 22 
For the SPWT, patients are instructed to walk continuously and at their own pace around an 23 
indoor 200m track, until they have to stop for back-related symptoms or other reasons. A 24 
maximum walking time limit of 30min has been proposed previously for patients that are little 25 
or asymptomatic.[23, 54, 55] Time is kept with a stop-watch and distance measured via a 26 
distance wheel or similar device. The main test result is the total walking distance (m), further 27 
results include total walking time (s), distance to first symptoms (DTFS) and walking speed 28 
(m/s). The intra-rater reliability was excellent for total walking distance (ICC=0.98), DTFS 29 
(ICC 0.94) and walking speed (ICC 0.80).[46, 55] In patients with LSS, total walking distance 30 
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ranged from 60–2065m (mean 776±726m, SD) and 67–1800s (mean 840±690s, SD).[54] The 1 
SEM and MCID of the SPWT have been reported to be 131 and 363m, respectively, in a 2 
small sample of 26 LSS patients.[55] The convergent validity with the MTT, self-estimated 3 
walking time and distance, as well as with symptoms of neurogenic claudication (back and leg 4 
pain, paresthesia, leg weakness, unsteadiness, ODI, SF-36 PCS and Swiss Spinal Stenosis 5 
Questionnaire (SSSQ)) were moderate to high.[23, 54] The SPWT outperformed the MTT in 6 
terms of internal (post-therapeutic) responsiveness, whereas external responsiveness 7 
(concordance with the patient’s subjective perception of change in clinical status) was 8 
relatively poor for both tests.[23] Comparative studies between the two tests indicated that 9 
LSS patients walked a higher absolute distance in the SPWT (mean 987±914m) as compared 10 
to the MTT (mean 611±666m; p<0.05), probably as the SPWT allows for greater (self-11 
selected) speed.[46] The SPWT also showed higher correlation with self-reported measures 12 
of pain, functional impairment and hrQoL than a digital activity monitor.[54]  13 
 14 
The SWT 15 
For the Shuttle Walking Test (SWT), participants are asked to walk a 10m course (32ft, 81in) 16 
on level ground and marked with cones at each end to complete one shuttle. Assistive 17 
devices (e.g., canes or walkers) are allowed if the participant normally uses them. The 18 
walking pace is monitored by a predetermined set of beeps from a sound-emitting device 19 
(CD-player, mp3-player, etc.), which indicate the amount of time allowed to walk one shuttle. 20 
The evaluation is progressive in that the time allowed between beeps for one shuttle gradually 21 
decreases. The test is maximal in that all participants are eventually unable to complete a 22 
shuttle in the allowed time, either for being short of breath or having too much pain or 23 
discomfort to continue. During the first minute of the test, beeps sound each 20s, and three 24 
shuttles (30m) are completed. During the second minute, four shuttles are completed; during 25 
the third minute five shuttles are completed; and so on up to 14 transits in 12 minutes, with a 26 
maximum total distance of 1020m.[56] The assessor counts the number of completed shuttles 27 
and the test result is the walking distance in meters (number of completed shuttles multiplied 28 
by 10). 29 
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The main test result is the total walking distance (m), for which excellent intra-rater reliability 1 
was reported (ICC 0.92-0.99).[56, 57] The SWT also demonstrated substantial changes in the 2 
functional status before and after surgery for LSS.[56, 57] For 95% certainty of change 3 
between two assessments in a single patient, the SWT should change by at least 76m.[56] In 4 
direct comparison with the MTT, the SWT exhibited similar test qualities for the assessment of 5 
patients with LSS, while evoking a lower level of cardiovascular stress.[58] 6 
 7 
The 6MWT 8 
The Six-Minute Walking Test (6MWT) is typically performed on a 3m wide and 30m long well 9 
illuminated flat hallway, according to the American Thoracic Society guidelines.[59] Patients 10 
are instructed to walk as fast as possible back and forth along the course for six minutes. 11 
Each minute, they are informed of the time and encouraged to continue. The main result of 12 
the test is the 6-minute walking distance (6MWD),[17, 60-62] traditionally documented by 13 
recording complete laps and using additional walkway marks every 3m for incomplete 14 
laps.[60, 62] Modifications with 5min walking time have been proposed,[51] but the majority of 15 
studies agree in the 6min assessment. Recently, a smartphone application has been 16 
programmed to allow measuring the 6MWD, as well as DTFS (m) and time to first symptoms 17 
(TTFS; s) in the patients home environment by GPS-coordinates (more information in 18 
Appendix B).[3]  19 
The 6MWT is less explored than the SPWT, MTT or the SWT in the context of lumbar DDD. A 20 
previous study found the 6MWD to range around 357±107m in n=29 LSS patients (mean ODI 21 
of 30.7±16.3), with a similar 6MWD in n=27 healthy control subjects (mean 408±73m).[62] 22 
The authors noticed a 6MWD increase by 21m around 10 weeks and by 26m around one 23 
year postoperatively, but the result did not differ significantly from the baseline assessment. In 24 
a Swedish multi-center RCT, mean 6MWD in surgical candidates with LSS with or without 25 
spondylolisthesis was in the range of 309–331m and improved by 70–80m at two years 26 
postoperatively.[61] More available literature on the 6MWT derives from other medical fields. 27 
In populations with various chronic cardio-pulmonary diseases, the MCID for the 6MWD 28 
ranged between 14.0–30.5m.[63] The MCID currently remains to be determined for lumbar 29 
DDD and in particular for LSS. 30 
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The 6MWT appears useful in particular for its ease of administration using smartphone apps, 1 
but also because it closely resembles ambulatory activities in which patients with lumbar DDD 2 
are limited.[17] 3 
 4 
Discussion 5 
This article provides an overview of currently available objective measures of function, applied 6 
to patients with degenerative diseases of the lumbar spine. Systematic review of the available 7 
literature yields some interesting findings.  8 
First, there was a significant and gradual increase in the reporting of objective measures of 9 
function over the last three decades. Second, there were a number of countries and scientific 10 
journals that appeared to be particularly interested in publishing research that employed 11 
objective measures of function. Third, and perhaps most important, we found that there was 12 
uncertainty pertaining to the reliability and validity of many of the objective measures applied 13 
in clinical studies. There was profound heterogeneity concerning the types of objective 14 
measure, their method of application, as well as regarding the definition of their main test 15 
results. Reporting of raw test values dominated the available literature and only few studies 16 
so far interpreted the results in a standardized fashion, adjusting for potential confounders 17 
such as age, BMI or gender. Given this variability across studies, comparison of cohorts in 18 
terms of OFI is currently limited.  19 
 20 
Is there a current “gold standard”? 21 
Based on the literature research there is no single “gold standard” for objective functional 22 
testing. Each physician and researcher must consider the type of function and impairment 23 
that is inherent to the patient he/she is going to examine. The TUG test, possibly combined 24 
with the 5R-STS test appears to be a reasonable choice, given both tests’ ease of 25 
administration. They only require a chair and a stopwatch, allowing them to be performed 26 
spontaneously, e.g. in case OFI is suspected in an outpatient consultation in clinics. Both 27 
tests were found to be reliable and valid for patients with lumbar DDD.[6, 8, 48] The TUG test 28 
was shown to be particularly sensitive in patients with predominant lumboradicular pain (e.g., 29 
LDH),[8, 9, 15] whereas the 5R-STS test was more adequate in patients with predominant 30 
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LBP.[48] Longer and more challenging reliable and validated tests such as the SPWT, MTT or 1 
6MWT may be chosen for LSS, considering that neurogenic claudication may not clinically 2 
manifest during examination with the shorter tests. For those planning to employ objective 3 
measures of function for research or clinical care, Table 2 summarizes existing options. 4 
 5 
Opportunities for future research 6 
There are some potential advantages of including objective measures of function in patient-7 
care and research. Some of them, in particular the modern motion-sensor or smartphone-8 
/GPS-based evaluations are a venue for passive and unobtrusive acquisition of longitudinal 9 
data, which could help overcome weaknesses inherent to current data collection such as 10 
missing data and loss of follow-up. Smartphones are integrated in virtually every aspect of our 11 
lives, having become a mirror of our behavior and likely very directly reflect change in 12 
behavior and loss of function, respectively. Further advantages include the usually high 13 
reliability versus high inter- and intra-observer variability of physician- and patient-rated 14 
measures, misinterpretation of questionnaire items and differences in the subjective scoring 15 
for educational, cultural and motivational reasons.[1] In contrast to subjective measures, 16 
objective outcome measures are applicable in foreign-language patients and illiterates. 17 
Presenting test-results as Z- or T-scores – expressing the patient’s deviation from the healthy 18 
population norm – enables comparison between different tests and across studies/cohorts.[6] 19 
While PROM results are usually difficult to interpret for nonmedical personnel such as the 20 
patient, relatives or the public, result interpretation is more obvious for objective tests. 21 
Objective outcome measures comply with the modern trend of patient empowerment and 22 
patient-centered healthcare and research.[64] Lastly, objective measures of function are well 23 
accepted by patients.[16] Convergent validity between objective outcome measures and 24 
PROMs was consistently weak to moderate, indicating that objective measures cannot 25 
replace PROMs. These measures may add a further dimension to the comprehensive patient 26 
evaluation.[8, 20] 27 
 28 
Need for standardization 29 
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This review revealed a variety of different assessments are available. For most the authors 1 
provided no reliability and validity measures. Even between studies that agreed on a similar 2 
type of objective measure, differences existed pertaining to the test protocol, definition of 3 
main outcome, and analytical approach. Also, objective tests of function can be heavily 4 
influenced by further neurological/orthopedic comorbidities (e.g., Parkinson’s disease, 5 
previous stroke, hip/knee osteoarthritis), and not all prior studies accounted for this. Deyo et 6 
al. recommended the introduction of uniform standards for measuring PROM-based outcome 7 
about 20 years ago.[65] This review now indicates a need for agreement in terms of objective 8 
test selection, conduction and analysis, which should facilitate future comparison of study 9 
results across cohorts, studies and countries. 10 
 11 
Strengths and limitations 12 
To the best of the author’s knowledge, there is no prior work that summarized currently 13 
available objective measures of function using a systematic approach. As such, this review 14 
may be a valuable resource for physicians when choosing one or several tests for patient 15 
care or research. Notwithstanding the systematic approach, additional articles may exist that 16 
we failed to identify. Furthermore, one may argue that excluding tests that measure certain 17 
aspects of the human body such as range of motion might be a weakness. However, this 18 
would have exceeded the scope of this article, and such a review was recently published.[66] 19 
Several studies included relatively low numbers of patients/subjects and more data on the 20 
objective measures of function will further increase our understanding of their specific value. 21 
Lastly, we were unable to perform a systematic assessment of the risk of bias in individual 22 




Clinical studies of patients with lumbar degenerative diseases increasingly employ objective 27 
measures of function, which offer high potential for patient-care and research. This review 28 
provides an overview on available options. Our findings call for an agreement and 29 
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standardization in terms of test selection, conduction and analysis to facilitate comparison of 1 
results across cohorts. 2 
  3 
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Appendix 4 
A. The “TUG” app is available free of charge in multiple languages at the Apple App 5 
Store (https://itunes.apple.com/de/app/tug-app/id1119087707?mt=8) and Google 6 
Play (https://play.google.com/store/apps/details?id=ch.webgearing.tugapp). 7 
B. The “6MWT” app will soon be available for smartphones and can then be downloaded 8 
free of charge in the Apple App Store 9 
(https://itunes.apple.com/us/app/6wt/id1454002232) or Google Play 10 
(https://play.google.com/store/apps/details?id=ch.webgearing.tugapp) in multiple 11 
languages, including English, German and French (more detailed information on the 12 
6MWT app will follow during the review process, once the final version has been 13 
uploaded in the app stores). 14 
C. Medline (Pubmed) search terms: ("goals"[MeSH Terms] OR "goals"[All Fields] OR 15 
"objective"[All Fields]) AND ("Assessment"[Journal] OR "assessment"[All Fields]) 16 
AND ("physiology"[Subheading] OR "physiology"[All Fields] OR "function"[All Fields] 17 
OR "physiology"[MeSH Terms] OR "function"[All Fields]) AND ("lumbar 18 
vertebrae"[MeSH Terms] OR ("lumbar"[All Fields] AND "vertebrae"[All Fields]) OR 19 
"lumbar vertebrae"[All Fields] OR ("lumbar"[All Fields] AND "spine"[All Fields]) OR 20 
"lumbar spine"[All Fields]) 21 
D. SCOPUS search terms: objective AND assessment AND function AND lumbar AND 22 
spine 23 
E. EMBASE search terms: 'objective assessment function lumbar spine' OR (objective 24 
AND ('assessment'/exp OR assessment) AND ('function'/exp OR function) AND 25 
lumbar AND ('spine'/exp OR spine)) 26 
F. Web of Science search terms: TOPIC: (objective assessment function lumbar spine) 27 
 28 
 29 




Table 1: Table detailing the inclusion and exclusion criteria, according to the PICOS 3 
(participants, interventions, comparators, outcomes, and study design) approach detailed in 4 
the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 5 
statement. An additional category, “Publications,” was added to primarily encompass the 6 
language restrictions. 7 
 Inclusion criteria Exclusion criteria 
Participants • Human subjects/patients with 
lumbar degenerative disc disease 
• Clinical setting 
• Animal subjects 
• Laboratory setting 
Interventions No intervention required No intervention required 
Comparators No comparator required No comparator required 
Outcomes • Objective measure, reflecting 
functional (dis)ability of a 
patient/human subject 
Reporting at least one of the 
following: 
• Test quality or feature 
(Agreement, reliability, validity, 
minimum clinically important 
difference, etc.) 
• Correlation with any subjective 
outcome measure 
• Satisfaction with outcome 
measure 
• Objective outcome measure used 
to determine therapeutic effect of 
a health-care intervention 
Either of the following: 
• No report of any objective test 
of patient/human subject 
function 
• Report of radiological 
outcomes, electrophysiological 
or kinematic function of the 
spine (e.g., electromyography 
or range of motion) only 
• Outcome data not sufficiently 
presented or provided upon 
request from the authors 
Study design Either of the following: 
• Randomized controlled trial 
• Quasi-experimental study 
• Observational study 
Either of the following: 
• Study protocols  
• Secondary research (review or 
meta-analysis of primary 
research) 
Publications Either of the following: 
• English language 
• German language 
• French language 
Either of the following: 
• Conference abstract 
• Letter, comment or note 
 8 
 9 
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Table 2: Comprehensive list of the objective tests that were applied, together with a brief 1 
description, the disease type, study type and objective, number of reported patients and 2 














































Participants begin with 
sitting on a chair. On the 
word “Go,” they get up 
and walk as fast as 
possible to a marked 
line on the floor at 3m 
distance. At this line, 
patients turn around, 
return to the chair and 
sit down again as 
quickly as possible. The 
test result is the time 
between getting up and 
sitting down again (s), 
using a stopwatch or the 
smartphone “TUG app”. 
Transformation of raw 
test values into age- and 
sex-standardized T-
scores to determine OFI 



















































2 MTT N=25; 
30.5% 
Patients walk on a 
treadmill, usually at a 
predefined protocol. 
Different studies have 
proposed different 
protocols in terms of 
speed, time or incline 
and there is no clearly 
superior or “gold 
standard” program (see 
article text). Test results 
are the time of onset or 
significant increase in 
symptoms (s), the total 
ambulation time (s), the 
total distance walked 
(m), as well as the 
maximum walking speed 
(m/s) for protocols that 


















































Participants sit down on 
an armless chair 
(standard height) with a 
hard seat, firmly placed 
against the wall. With 
arms folded across the 
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on the ground 
participants then stand 
up fully and sit back 
down again without 
using the upper 
limbs.[18, 48] The test 
result is the time needed 
until the complete 
standing position is 




asked patients to 
perform five repetitions 
of the test, measuring 
the overall time to 
complete, with a 




















A number of studies 
have applied various 
wearable devices on the 
body (usually throughout 
the day only) that 
measure acceleration 
and filter these raw 
acceleration data into a 
metric known as activity 
counts, representing the 
intensity of physical 
activity. Some devices 
include further functions 
such as altimeters. 
Depending on the 
device, the number of 
steps taken, distance 
walked (m), or calories 
expended can be 
calculated. There is a 
body of literature 
supporting that 
accelerometers are 
reliable and provide a 
valid indicator of overall 









































continuously at their own 
pace around a 200m 
track, until they have to 
stop for back-related 
symptoms or other 
reasons. Time is kept 
with a stop-watch and 
distance measured via a 
distance wheel or similar 
device. The main test 
result is the total walking 
distance (m), further 
results include TAT (s), 






























54, 55, 79, 


















62, 72, 81, 
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ysis walkways containing 
pressure sensors,[53] 
reflective markers on 
participants and infrared 
cameras,[40, 72, 84] 
infrared-emitting diodes 
on participants captured 
by motion analysis 
systems,[85] inertial 
sensors [62] or sensor-
equipped smart shoes 
[86] to calculate 
spatiotemporal 
parameters, such as 
walking velocity, stride 
length, step width, gait 
cycle times (on defined 
gait cycles) among 
others. Usually several 
barefoot gait cycles are 
performed per 
participant. The systems 
were reported as reliable 































For the 10- or 15m 
walking test, participants 
are instructed to walk (at 
a comfortable [87] or at 
maximum speed [51, 88, 
89]) on a flat, straight 
10- or 15m walkway.[17] 
Most groups have used 
a 10m distance; the 15m 
distance was used 
once.[51] The test result 
is the time to complete 
the selected distance 
(s).[17, 88, 89] One 
group evaluated patients 
by their ability to run 
rather than walk the 




































Participants walk a 10m 
course on level ground 
and marked with cones 
at each end to complete 
one shuttle. Assistive 
devices are allowed if 
the participant normally 
uses them. The walking 
pace is monitored by a 
predetermined set of 
beeps from a sound-
emitting device, which 
indicate the amount of 
time allowed to walk one 
shuttle. The evaluation 
is progressive in that the 
time allowed between 
beeps for one shuttle 
gradually decreases. All 
participants are 
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complete a shuttle in the 
allowed time. The test 
includes a maximum of 
14 transits in 12 min, 
with a maximum total 
distance of 1020m.[56] 
The assessor counts the 
number of completed 
shuttles and the test 
result is the walking 
distance (m; number of 
completed shuttles 





Participants walk as fast 
as possible back and 
forth along a flat hallway 
for six minutes. They are 
informed of the time and 
encouraged each 
minute. The main result 
of the test is the 6MWD 
(m),[17, 60-62] 
traditionally documented 
by recording complete 
laps and using walkway 
marks for incomplete 
laps.[60, 62] A 
smartphone application 
has been programmed 
to measure the 6MWD, 
as well as TTFS and 














































Participants sit in their 
preferred posture on a 
stationary bicycle 
ergometer, holding the 
handlebars with both 
hands. Throughout the 
entire test, they are 
instructed to continue at 
a constant pedaling 
speed of 50–60rpm. No 
resistance is added for 
the first minute, but 
resistance is increased 
to 20W (≈150kpm/m) for 
the second, and to 50W 
(≈300kpm/m) for 
additional eight minutes. 
The total maximum test 
time is 10min, if the 
patient does not have to 
stop earlier. The test 
result is the time that the 
patient pedaled (s), as 
well as the total distance 
(m). Pain and/or 
paresthesia can be 
measured before and 
after the test; the TTFS 













































walkway at their 
preferred speed. Having 
ample space before and 
after the walking space 
is required to ensure 
that walking speed is 
constant.[18] The main 
test results is the time 
(s) taken to complete the 
walk (single trial [18, 50] 
or mean of six trials 
[92]), whereas number 
of steps, walking velocity 

















12 AST N=2; 
2.4% 
For the alternative step 
test (AST), the entire left 
and right foot (shoes 
removed) alternatively 
have to be placed as 
fast as possible onto a 
step with a distinct 
height (e.g. 18cm) and 
depth (e.g. 40cm). The 
time taken to take eight 
steps comprises the test 
measure (s). The AST is 
used to evaluate a 
participant’s ability to 
maintain standing 
balance while 
performing a potentially 
destabilizing activity, 
such as standing on one 


























For the weight carrying 
(WC) test participants 
walk 20m as fast as 
possible while carrying 
10% of their body weight 
evenly distributed in 
hand-held weights. The 
test result is the time 


































unsupported, for as long 
as possible (maximum 
of 30s). The test result is 
the time until failing to 


































GPS is used to track 
position- and movement 
data of participants 
during the day in 
intervals of about 10s. 
Outcomes include total 
distance walked, 
average distance, 
walking speed and total 
walking duration per 
day. Precision of 
measurements of about 
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conditions) have been 
reported.[93] The data 
have to be pre-
processed using 
complex algorithms and 






This test requires an 
industrial force plate 
balance platform, 
designed for testing 
postural stability/trace 
length, indicating how 
far the participant shifts 
from the center of 
pressure over a 20s 
period while performing 
balance tasks. The test 





















Participants are timed as 
they descent twelve 
steps with a defined 
depth (e.g. 28cm) and 
height (e.g. 17cm) “as 
quickly and as safely as 
possible”. The test result 
is the time (s) and an 


















Participants walk 2.44m 
at their usual (self-
selected) pace, 






















Participants sit and 
stand as long as 
possible. The test result 
is the maximum duration 


























Participants walk up and 
down a staircase with 
five stairs for 1min. The 
test result is the number 
of stairs climbed during 
















For the progressive 
isoinertial lifting 
evaluation (PILE) 
participants lift a box 
with a weight four times 
within 20s from the floor 
up to a 75cm-high table. 
Starting weights and 
incremental weights are 
different for men and 
women. The starting 
weight for women is 3.6 
kg and 5.85 kg for men 
(weight of box included). 
After each completed 











53 2.93 [51] 
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for women is increased 
by 2.25 kg and for men 
by 4.5 kg. The test stops 
when the participant 
cannot lift the box four 
times within 20s, the 
participant decides to 
stop, the heart rate 
exceeds 85% of the 
maximal heart rate, the 
maximal amount of the 
weight that could safely 
be lifted is reached (60% 
of participant’s body 
weight), or the test 
observer considers 
further lifting unsafe. 
The test result is the 
number of fully 
completed lifting stages. 
* Subjects include both patients and controls. 1 
  2 
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Figure legends 1 
Figure 1: PRISMA flowchart detailing the process for the selection of papers.  2 
Figure 2: Line graph highlighting the significant (p<0.001) annual increase in the number (#) 3 
of publications (y-axis) over the last decades (x-axis). 4 
Figure 3: Histogram indicating the number (#) of publications (y-axis) that employed an 5 
objective measure of function per country (x-axis). 6 
Supplemental Figure 1: Histogram indicating the number (#) of publications (y-axis) that 7 
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